T-DM1 Tops Capecitabine-Lapatinib in Advanced HER2-Positive Breast Cancer June 3, 2012OncologyWomen's Health
Intermittent Hormone Therapy Shortens Prostate Cancer SurvivalJune 3, 2012GeriatricsOncologyMen's Health
Liver Cancer Rates Continue to Rise, Vigilance WarrantedJune 1, 2012DiabetesObesityGastroenterologyInfectious Diseases
